Project start date: 01-Apr-2023 Project end date: 30-Jun-2026
Congenital Insensitivity to Pain - Epidemiology and Management
Age range for cases: Patients aged one month to 18 years
Dr Alasdair Parker - Consultant paediatric neurologist
alasdair.parker@nhs.net
Box 107, Addenbrooke’s Hospital, Cambridge CB2 0QQ Professor
Geoff Woods - Honorary Consultant in Medical Genetics
cw347@cam.ac.uk
Department of Clinical Genetics, Addenbrooke’s Hospital, Cambridge CB2 0QQ
Medical history of behaviours / injuries and response to injuries, visible proof of lack of nociception in a conscious individual
And
Self-mutilation and / or injuries to lips and/ or digits or permanent joint deformity Or Disease causing variant (s) in known CIP genes SCN9a, SCN11a, PRDM12, NTRK1, CLTCL1, NGF and ZFHX2
Patients who have a raised threshold to pain sensation, but which can be explained by a coexisting underlying neurological disorder e.g., autism, confirmed other hereditary/sensory/autonomic neuropathy
No Self-mutilation and injuries to lips and/ or digits or permanent joint deformity
Confirmed diagnosis of other neurological disease not causing congenital insensitivity to pain